General Genomics Inc.

Curo46 - Artificial Intelligence (Powered) Personalized Health Software

https://wefunder.com/general.genomics

Total raised on Wefunder: 26350

Total investors: 15

Quick facts

  • Stonebridge Advisory Inc. rendered a current fair market value estimated at $320,000,000.
  • Diseases and treatments affect everyone differently.
  • Underlying relationships are too complex to be understood by today’s health and medical industries.
  • Curo46’s AI revolutionizes our understanding of an individual’s health risks.
  • Our interface gives people control over their health/medical history and who gets access to it.
  • Our applications are fully protected and supported with patents.
  • Existing contracts with the government, military, education institutions, and countless companies.
  • Be at the forefront of revolutionizing a 100 Billion Dollar Industry bringing AI into healthcare.

Team profiles

Featured investor profiles

General Genomics Inc.

Curo46 - Artificial Intelligence (Powered) Personalized Health Software

Funded badge
Last Funded June 2021

$26,350

raised from 15 investors
Pitch Video
Investor Panel

Investor Panel

Joseph and Shu interviewed General Genomics Inc. on November 14, 2020. Play Video
Joseph Schinaman
Joseph Schinaman
Shu Li
Shu Li
CEO and co-founder of Petri-Bio
Strengths
says, "A team of very experienced founders are using their frontier technology to help people better understand and manage their health condition. As impact-driven entrepreneurs, they are also launching the pilot test to evaluate people’s risk of covid infection as a free service. "
says, "If they figure out the tech to do this right, the upside is enormous. Covid susceptibility is a good jumping-off point, but the real upside would be in applying this to other disease states. Many diseases have plenty of existing therapeutics, but the efficacy of each varies from patient to patient. Using this sort of technology to make better decisions about who is likely to respond to what treatment is a tremendous opportunity. "
Advice
says, "There are so many great things about this company! We would have loved to learn a bit more about the competition in the field and regulatory paths."
says, "Medical diagnostic tools are a highly regulated industry, so the team needs to take care to navigate this route correctly. "

What Investors Say

Managing Member, Snubble Tubble LLC
LEAD INVESTOR
Invested $250,000 this round
General Genomics is an impressive team of brilliant, innovative and genuinely good people who share a sincere passion for making this world a better place using the next frontier...artificial intelligence and machine learning.  The GGI team work ethic is one to emulate.  As a veteran, I am honored to invest in and work with my veteran brothers, AJ Rosenthal and Caleb Stuart.  AJ, Caleb and Warren are revolutionaries who are challenging humanity to STEP IT UP!
What People Say